Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix® 30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-mont...

por Shah, S, Benroubi, M, Borzi, V, Gumprecht, J, Kawamori, R, Shaban, J, Shestakova, M, Wenying, Y, Valensi, P
Publicado 2009

Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix® 30) can improve glycaemic control in patients treated with basal insulins: a subgroup analysis of the IMPROVE™...

por Gumprecht, J, Benroubi, M, Borzi, V, Kawamori, R, Shaban, J, Shah, S, Shestakova, M, Wenying, Y, Ligthelm, R, Valensi, P
Publicado 2009